Cargando…
Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
Parkinson's disease (PD) is the most frequent of all Lewy body diseases, a family of progressive neurodegenerative disorders characterized by intra-neuronal cytoplasmic inclusions of α-synuclein. Its most defining features are bradykinesia, tremor, rigidity and postural instability. By the time...
Autores principales: | Vermeiren, Yannick, Hirschberg, Yael, Mertens, Inge, De Deyn, Peter P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373724/ https://www.ncbi.nlm.nih.gov/pubmed/32760338 http://dx.doi.org/10.3389/fneur.2020.00595 |
Ejemplares similares
-
Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease
por: De Groote, Evelien, et al.
Publicado: (2020) -
Clinical and Imaging Markers of Prodromal Parkinson's Disease
por: Hustad, Eldbjørg, et al.
Publicado: (2020) -
Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor
por: Wang, Xi-Xi, et al.
Publicado: (2020) -
Editorial: Prodromal Parkinson's Disease
por: Crosiers, David, et al.
Publicado: (2021) -
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
por: Sportelli, Carolina, et al.
Publicado: (2020)